GENE ONLINE|News &
Opinion
Blog

Kathy Huang

We are, and will remain, perpetual newbies. - Kevin Kelly

WRITTEN BY Kathy Huang

Japanese Software Company Acquires Insilico to Build Bioprocess Solutions
2021-11-03
South Korea Approves EUA for Moderna’s COVID-19 Vaccine Produced by Samsung Biologics
2021-10-28
South Korea’s D&D Pharmatech Secures $51M Series C, Eyes 2022 IPO
2021-10-20
2021 BioJapan Highlights: How Can Metabolomics and Lipidomics Deepen Microbiome Research?
2021-10-14
Zai Lab, Turning Point’s Solid Tumor Treatment Repotrectinib Gets FDA Breakthrough Therapy Designation
2021-10-06
Taiwan’s Biotech Industry, Lackluster or Late Bloomer? A Breakdown of Policies, Hotspots, and Market Movements
2021-10-05
CYTENA Bioprocess Solutions Closes $5M Funding to Develop Automatic High-throughput Screening Platform for Pharmaceuticals
2021-10-05
I-Mab Gets China NMPA Greenlight to Trial Combination Therapy in Solid Tumors
2021-09-30
FDA Approves Samsung Bioepis and Biogen’s Lucentis Biosimilar
2021-09-22
Revealing the Underestimated Potential of Natural RNA Editing – An Interview with Dr. Trees-Juen Chuang
2021-09-17
Sinovac to Supply Additional 101,000 COVID-19 Vaccine Doses to Singapore
2021-09-16
Takeda to Supply 150 Million Doses of Novavax COVID-19 Vaccine to Japan
2021-09-08
South Korea’s Boryung Launches Avastin Biosimilar Developed by Samsung Bioepis
2021-09-02
Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara
2021-08-26
New Era in Precision Medicine? Introduction & Overview of RNA Editing
2021-08-23
1 2
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!